Chondartron is an injection solution for dogs and cats for diseases of the musculoskeletal system. In appearance, the drug is a colorless transparent liquid.
As active ingredients, Chondartron for injection contains matrix tinctures of plant, organic origin and mineral components (in 1000 ml): Rhododendron O = D1 20 Вµl; Rhus toxicodendron 4 Ојl; Ledum palustre O = D1 0.2 Ојl; Symphytum 9 Ојl; Apis mellifica O = D1 1 nl; Causticum Hahnemanni D4 1 mg; Calcium fluoratum D4 1 Ојg; Lithium carbonicum D4 1 mcg; Sulfur O = D4 0.1 ml; Comarum palustre 40 nl and auxiliary substances: methyl parahydroxybenzoate - 0.5 g, sodium chloride - 5.8 g, sodium acetate tri hydrate - 2.0 g, hydrochloric acid to pH 5.4, ethyl alcohol 95% - 5.26 g, water for injection up to 1000 ml.
Chondartron belongs to the combined homeopathic medicines. It has anti-inflammatory, analgesic, chondroprotective and regenerating effects in diseases of the musculoskeletal system in dogs and cats.
According to the degree of impact on the body, the drug belongs to low-hazard substances (hazard class 4 according to GOST 12.1.00776), does not have a local irritant and sensitizing effect.
Hondartron is prescribed to dogs and cats for prevention and treatment of: acute diseases of the joints and periarticular structures (arthritis, bursitis, synovitis, etc.); diseases and injuries of the tendon-ligamentous apparatus (tendonitis, tendovagnet, sprains, partial ruptures of the tendons, etc.); osteoarthritis, including those resulting from various osteochondropathies; arthrosis; recovery after surgery on joints and tendon-ligamentous apparatus.
DOSAGE AND APPLICATION
Chondartron injection is administered intramuscularly or subcutaneously 2-3 times a day for 10-14 days: for dogs and cats: 0.1 ml per 1 kg of animal weight (min. 0.5 ml, max. 4.0 ml); horses 8.0-10.0 ml; cattle 5.0 ml; calves 2.5-3.0 ml; sheep, goats 3.0 ml.
Overdose symptoms in animals have not been established.
The peculiarities of the action of the drug during its first use and cancellation have not been established.
Avoid gaps in the introduction of the next dose of the drug, as this can lead to a decrease in therapeutic and prophylactic efficacy. If one dose is missed, the use of the drug should be resumed as soon as possible in the same dose and according to the same scheme.
The use of Hondartron does not exclude the use of other drugs for etiotropic, pathogenetic and symptomatic therapy.
Chondartron is not intended for use in productive animals.
A contraindication to the use of a drug is the individual hypersensitivity of the animal to its components.
When using Chondartron in accordance with this instruction, side effects and complications, as a rule, are not noted. With increased individual sensitivity and the manifestation of allergic reactions, the use of the drug is discontinued and the animal is prescribed antihistamines and symptomatic therapy.
SHELF LIFE AND STORAGE
Chondartron is stored in the manufacturer's sealed packaging, separately from food and feed, in a dry place protected from direct sunlight, at a temperature from 0 В° C to 25 В° C.
The shelf life of the drug, subject to storage conditions in a sealed manufacturer's packaging in a sealed package, is 3 years from the date of production, after the first opening of the bottle - 30 days. It is forbidden to use after the expiration date.
Should be stored out of the reach of children. Unused medicinal product is disposed of in accordance with legal requirements.
Hondartron is released for injection packaged in 10 ml each in glass vials, sealed with rubber stoppers and rolled in aluminum caps. Vials of 10 ml are individually packed in individual cardboard boxes. Each packing unit is accompanied by instructions for use.
from 0 to +25
for dogs and cats with diseases of the musculoskeletal system